185 related articles for article (PubMed ID: 36152903)
1. The O-GlcNAcylation and its promotion to hepatocellular carcinoma.
Zhang J; Xun M; Li C; Chen Y
Biochim Biophys Acta Rev Cancer; 2022 Nov; 1877(6):188806. PubMed ID: 36152903
[TBL] [Abstract][Full Text] [Related]
2. O-GlcNAcylation promotes the migratory ability of hepatocellular carcinoma cells via regulating FOXA2 stability and transcriptional activity.
Huang H; Wu Q; Guo X; Huang T; Xie X; Wang L; Liu Y; Shi L; Li W; Zhang J; Liu Y
J Cell Physiol; 2021 Nov; 236(11):7491-7503. PubMed ID: 33843053
[TBL] [Abstract][Full Text] [Related]
3. O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantation.
Zhu Q; Zhou L; Yang Z; Lai M; Xie H; Wu L; Xing C; Zhang F; Zheng S
Med Oncol; 2012 Jun; 29(2):985-93. PubMed ID: 21461968
[TBL] [Abstract][Full Text] [Related]
4. O-GlcNAc modified-TIP60/KAT5 is required for PCK1 deficiency-induced HCC metastasis.
Liu R; Gou D; Xiang J; Pan X; Gao Q; Zhou P; Liu Y; Hu J; Wang K; Tang N
Oncogene; 2021 Dec; 40(50):6707-6719. PubMed ID: 34650217
[TBL] [Abstract][Full Text] [Related]
5. O-GlcNAcylation in health and neurodegenerative diseases.
Lee BE; Suh PG; Kim JI
Exp Mol Med; 2021 Nov; 53(11):1674-1682. PubMed ID: 34837015
[TBL] [Abstract][Full Text] [Related]
6. Modification of histones by sugar β-N-acetylglucosamine (GlcNAc) occurs on multiple residues, including histone H3 serine 10, and is cell cycle-regulated.
Zhang S; Roche K; Nasheuer HP; Lowndes NF
J Biol Chem; 2011 Oct; 286(43):37483-95. PubMed ID: 21896475
[TBL] [Abstract][Full Text] [Related]
7. O-GlcNAcylation of amyloid-β precursor protein at threonine 576 residue regulates trafficking and processing.
Chun YS; Kwon OH; Chung S
Biochem Biophys Res Commun; 2017 Aug; 490(2):486-491. PubMed ID: 28624365
[TBL] [Abstract][Full Text] [Related]
8. Hyper-O-GlcNAcylation of YB-1 affects Ser102 phosphorylation and promotes cell proliferation in hepatocellular carcinoma.
Liu Q; Tao T; Liu F; Ni R; Lu C; Shen A
Exp Cell Res; 2016 Dec; 349(2):230-238. PubMed ID: 27751836
[TBL] [Abstract][Full Text] [Related]
9. Methods for the Detection, Study, and Dynamic Profiling of O-GlcNAc Glycosylation.
Thompson JW; Griffin ME; Hsieh-Wilson LC
Methods Enzymol; 2018; 598():101-135. PubMed ID: 29306432
[TBL] [Abstract][Full Text] [Related]
10. Gluconeogenic enzyme PCK1 deficiency promotes CHK2 O-GlcNAcylation and hepatocellular carcinoma growth upon glucose deprivation.
Xiang J; Chen C; Liu R; Gou D; Chang L; Deng H; Gao Q; Zhang W; Tuo L; Pan X; Liang L; Xia J; Huang L; Yao K; Wang B; Hu Z; Huang A; Wang K; Tang N
J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33690219
[TBL] [Abstract][Full Text] [Related]
11. High dietary fructose promotes hepatocellular carcinoma progression by enhancing O-GlcNAcylation via microbiota-derived acetate.
Zhou P; Chang WY; Gong DA; Xia J; Chen W; Huang LY; Liu R; Liu Y; Chen C; Wang K; Tang N; Huang AL
Cell Metab; 2023 Nov; 35(11):1961-1975.e6. PubMed ID: 37797623
[TBL] [Abstract][Full Text] [Related]
12. O-GlcNAcylation: an important post-translational modification and a potential therapeutic target for cancer therapy.
Lu Q; Zhang X; Liang T; Bai X
Mol Med; 2022 Sep; 28(1):115. PubMed ID: 36104770
[TBL] [Abstract][Full Text] [Related]
13. New insights: A role for O-GlcNAcylation in diabetic complications.
Peterson SB; Hart GW
Crit Rev Biochem Mol Biol; 2016; 51(3):150-61. PubMed ID: 26806492
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of OGT by Caveolin-1 promotes hepatocellular carcinoma cell migration and invasion.
Wang L; Feng Y; Zhang C; Chen X; Huang H; Li W; Zhang J; Liu Y
Cell Biol Int; 2021 Nov; 45(11):2251-2263. PubMed ID: 34288245
[TBL] [Abstract][Full Text] [Related]
15. O-GlcNAcylation: a novel pathway contributing to the effects of endothelin in the vasculature.
Lima VV; Giachini FR; Hardy DM; Webb RC; Tostes RC
Am J Physiol Regul Integr Comp Physiol; 2011 Feb; 300(2):R236-50. PubMed ID: 21068200
[TBL] [Abstract][Full Text] [Related]
16. O-GlcNAcylation of RACK1 promotes hepatocellular carcinogenesis.
Duan F; Wu H; Jia D; Wu W; Ren S; Wang L; Song S; Guo X; Liu F; Ruan Y; Gu J
J Hepatol; 2018 Jun; 68(6):1191-1202. PubMed ID: 29454068
[TBL] [Abstract][Full Text] [Related]
17. Potential coordination role between O-GlcNAcylation and epigenetics.
Wu D; Cai Y; Jin J
Protein Cell; 2017 Oct; 8(10):713-723. PubMed ID: 28488246
[TBL] [Abstract][Full Text] [Related]
18. Translocation of HSP27 into liver cancer cell nucleus may be associated with phosphorylation and O-GlcNAc glycosylation.
Guo K; Gan L; Zhang S; Cui FJ; Cun W; Li Y; Kang NX; Gao MD; Liu KY
Oncol Rep; 2012 Aug; 28(2):494-500. PubMed ID: 22664592
[TBL] [Abstract][Full Text] [Related]
19. O-GlcNAcylation of histone deacetylases 1 in hepatocellular carcinoma promotes cancer progression.
Zhu G; Tao T; Zhang D; Liu X; Qiu H; Han L; Xu Z; Xiao Y; Cheng C; Shen A
Glycobiology; 2016 Aug; 26(8):820-833. PubMed ID: 27060025
[TBL] [Abstract][Full Text] [Related]
20. Protein O-GlcNAcylation impairment caused by N-acetylglucosamine phosphate mutase deficiency leads to growth variations in Arabidopsis thaliana.
Jia X; Zhang H; Qin H; Li K; Liu X; Wang W; Ye M; Yin H
Plant J; 2023 May; 114(3):613-635. PubMed ID: 36799458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
